2025. NEUROPROTECTIVE EFFECTS OF SEMAGLUTIDE AND TIRZEPATIDE DURING THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS. Editora Impacto Científico. (Nov. 2025), 137–145.